The estimated Net Worth of Eugene D Rabe is at least $19.1 Million dollars as of 17 November 2004. Eugene Rabe owns over 50,000 units of Abiomed stock worth over $19,051,000 and over the last 21 years Eugene sold ABMD stock worth over $0.
Eugene has made over 11 trades of the Abiomed stock since 2003, according to the Form 4 filled with the SEC. Most recently Eugene exercised 50,000 units of ABMD stock worth $329,500 on 17 November 2004.
The largest trade Eugene's ever made was exercising 50,000 units of Abiomed stock on 17 November 2004 worth over $329,500. On average, Eugene trades about 13,077 units every 29 days since 2003. As of 17 November 2004 Eugene still owns at least 50,000 units of Abiomed stock.
You can see the complete history of Eugene Rabe stock trades at the bottom of the page.
Eugene's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Abiomed have traded over $148,507,587 worth of Abiomed stock and bought 232,354 units worth $4,276,073 . The most active insiders traders include Michael R Minogue, Eric A Md Rose, and David M Weber. On average, Abiomed executives and independent directors trade stock every 16 days with the average trade being worth of $5,341,900. The most recent stock trade was executed by Martin P Sutter on 17 February 2022, trading 4,000 units of ABMD stock currently worth $1,258,840.
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Abiomed executives and other stock owners filed with the SEC include: